Abstract
Objective: In 2017, there was an estimated 350,000 women living with human immunodeficiency virus (HIV) in Ethiopia. Primary cancers including vulvar cancer are increased among HIV women, which is associated with the numbers of years of HIV infection and compliance with antiretroviral therapy (ART). In 2013, the Addis Ababa city cancer registry reported a vulvar cancer incidence of 1.4 per 100,000 women. In 2016, a gynecologic oncology clinical service was initiated with the start of the gynecologic oncology fellowship training program in Addis Abba at St. Paul’s Hospital Millennium Medical College (SPHMMC). Surgical and chemotherapy can be delivered at SPHMMC, but lack of radiation therapy, an average delay greater than 6 months, limits access to definitive radiation treatment for women with vulvar cancer. The aim of this study is to report early data on the trend of vulvar cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
